Pfizer shares fall as 2024 revenue and profit forecast disappoints
Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street's expectations, as it sees weak demand for its once-blockbuster Covid products. Pfizer also raised the target of its sweeping cost-cutting plan by $500 million, bringing the anticipated total to…#pfizer #refinitiv #pfizercfo #davedenton #seagen #merck #bristolmyerssquibb #abbvie (Source: Reuters: Health)
Source: Reuters: Health - December 13, 2023 Category: Consumer Health News Source Type: news
Pfizer Stock Sinks To 10-Year Low —Why Investors Have Soured On Covid-Era Giant
Shares of the Covid vaccine manufacturer are down about 50% this year. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2023 Category: Pharmaceuticals Authors: Derek Saul, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Education topline Source Type: news
PET/CT shows impact of different COVID-19 vaccines
The type of COVID-19 vaccine and the time interval between vaccination and PET/CT scans are key factors in minimizing false interpretations in cancer patients, according to research published December 9 in Scientific Reports.
The study is the first to examine systemic response changes in patients in correlation to time after COVID-19 vaccination using three different vaccines, and may help minimize dilemmas for clinicians, wrote first author Tina Nazerani-Zemann, MD, of the Medical University of Graz in Austria, and colleagues.
“Different vaccines cause different system metabolic changes. The knowledge of vaccine type,...
Source: AuntMinnie.com Headlines - December 13, 2023 Category: Radiology Authors: Will Morton Source Type: news
R.S.V. Vaccine Is Slow to Reach Its Target: Older Americans
The virus sends up to 160,000 people over 65 to hospitals every year. But just 15 percent have gotten the newly available shots. (Source: NYT Health)
Source: NYT Health - December 9, 2023 Category: Consumer Health News Authors: Paula Span Tags: Vaccination and Immunization Elderly Respiratory Syncytial Virus (RSV) Age, Chronological Medicine and Health Respiratory Diseases Viruses Centers for Disease Control and Prevention Food and Drug Administration GSK PLC Pfizer Inc you Source Type: news
Man, 65, in Los Angeles develops a 'cheesy' yellow tumor on his shoulder after bizarre reaction to Pfizer Covid vaccine
A California man developed a non-cancerous tumor after receiving the Pfizer Covid vaccine, doctors have revealed. The benign tumor starts from the base of a hair follicle and grows. (Source: the Mail online | Health)
Source: the Mail online | Health - December 8, 2023 Category: Consumer Health News Source Type: news
White House announces readiness to deploy ‘march-in rights’ to target high drug prices
The Biden administration is rolling out a framework to enforce the government’s march-in authorities on drugs developed with taxpayer dollars, saying if drugmakers refuse to make their products “reasonably” available, then the government is prepared to give other companies license to produce those…#trump #nih #neeratanden #berniesanders #moderna #pfizer #hhs #commerce #tanden #laelbrainard (Source: Reuters: Health)
Source: Reuters: Health - December 7, 2023 Category: Consumer Health News Source Type: news
Column: A bogus new attack on COVID vaccines from Texas' least credible politician
Texas Attorney General Ken Paxton unveils a fact-free lawsuit questioning Pfizer's COVID vaccine, which has helped to save millions of people from hospitalization and death. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - December 6, 2023 Category: Science Authors: Michael Hiltzik Source Type: news
AI Update: Industry Moves On Data Provenance, Microsoft Joins OpenAI Board
With many AI-related lawsuits hinging on who has the right to the intellectual property used to train large language models, a coalition of companies that includes American Express, Humana, IBM, Pfizer, UPS, and Walmart have launched the Data & Trust Alliance, a nonprofit organization with the…#americanexpress #humana #ibm #pfizer #walmart #datatrustalliance #openai #brettaylor #salesforce #bloomberglaw (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2023 Category: Consumer Health News Source Type: news
Diamonds in the Rough: 3 Undervalued Stocks with Huge Upside
Find out which under-covered stocks are hidden gems In the stock market, value is often found in places that other investors might miss. So, the first main quality of hidden gem stocks is their undervaluation. Next, they must have substantial earnings growth potential. Investors want growth since…#sp500 #pfizer #fda #cdc #pfe #deltaairlines #dal #dalseps #eps #delta (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2023 Category: Consumer Health News Source Type: news
Pfizer ’s Weight-Loss Pill Disappointment Is an Opening for Biotech Rivals
The disappointing data Pfizer announced on its obesity pill are opening up opportunities for biotechs developing their own oral weight-loss drugs. (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2023 Category: Consumer Health News Source Type: news
Cramer on Monday's market action: Some investors are headed for a'nasty hangover '
CNBC's Jim Cramer on Monday suggested that investors are not buying with a clear head and are choosing too many poorly-performing stocks. "I saw a hammered market, a market where the buyers have gotten drunk as a proverbial skunk, buying the worst of the worst," he said. "And when you get…#jimcramer #esteelauder #beauty #moderna #pfizer #postcovid (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2023 Category: Consumer Health News Source Type: news
Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects
Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with high rates of side effects such as nausea and vomiting.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Pfizer announces topline Phase 2b results of oral GLP-1R agonist, danuglipron, in adults with obesity
Pfizer Inc. (NYSE: PFE) announced topline data from the Phase 2b clinical trial (NCT04707313) investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate, danuglipron (PF-06882961), in adults with obesity and without type 2 diabetes. The study met its primary endpoint demonstrating statistically significant change in body weight from baseline. (Source: World Pharma News)
Source: World Pharma News - December 4, 2023 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
DNA Sequence In Pfizer COVID-19 Vaccine Could Spur New Lawsuits: Lawyers
Authored by Zachary Stieber via The Epoch Times (emphasis ours), Pfizer and its partner BioNTech could be open to lawsuits for including a DNA sequence in their COVID-19 vaccine. A woman walks by Pfizer's headquarters in New…#covid19vaccine #zacharystieber #epochtimes #pfizer #newyorkcity #kenabetancurafp #publicreadiness #prepact #matstaver #libertycounsel (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2023 Category: Consumer Health News Source Type: news
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Pfizer' s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences. The drugmaker on Friday said it will stop developing the twice-daily treatment, danuglipron, after obese patients…#pfizer #danuglipron #obese #novonordisk #elililly #mounjaro #eisai #fda #lorcaserin #belviq (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2023 Category: Consumer Health News Source Type: news
